- Home
- TNYA vs MCN Comparison
TNYA vs MCN Comparison
Compare TNYA & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNYA
- MCN
- Stock Information
- Founded
- TNYA 2016
- MCN 2004
- Country
- TNYA United States
- MCN Canada
- Employees
- TNYA N/A
- MCN N/A
- Industry
- TNYA Medicinal Chemicals and Botanical Products
- MCN
- Sector
- TNYA Health Care
- MCN
- Exchange
- TNYA Nasdaq
- MCN Nasdaq
- Market Cap
- TNYA 119.2M
- MCN 141.5M
- IPO Year
- TNYA 2021
- MCN N/A
- Fundamental
- Price
- TNYA $1.43
- MCN $6.64
- Analyst Decision
- TNYA Strong Buy
- MCN
- Analyst Count
- TNYA 4
- MCN 0
- Target Price
- TNYA $17.33
- MCN N/A
- AVG Volume (30 Days)
- TNYA 6.3M
- MCN 52.9K
- Earning Date
- TNYA 11-06-2024
- MCN 01-01-0001
- Dividend Yield
- TNYA N/A
- MCN 9.96%
- EPS Growth
- TNYA N/A
- MCN N/A
- EPS
- TNYA N/A
- MCN N/A
- Revenue
- TNYA N/A
- MCN N/A
- Revenue This Year
- TNYA N/A
- MCN N/A
- Revenue Next Year
- TNYA N/A
- MCN N/A
- P/E Ratio
- TNYA N/A
- MCN N/A
- Revenue Growth
- TNYA N/A
- MCN N/A
- 52 Week Low
- TNYA $0.99
- MCN $6.69
- 52 Week High
- TNYA $7.01
- MCN $8.60
- Technical
- Relative Strength Index (RSI)
- TNYA 37.10
- MCN 37.25
- Support Level
- TNYA $1.33
- MCN $6.52
- Resistance Level
- TNYA $1.63
- MCN $6.83
- Average True Range (ATR)
- TNYA 0.15
- MCN 0.08
- MACD
- TNYA 0.01
- MCN 0.00
- Stochastic Oscillator
- TNYA 18.92
- MCN 29.63
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.
About MCN Madison Covered Call & Equity Strategy Fund
XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide a high level of current income and gains, with a secondary objective of capital appreciation.